Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other 2Endocrine 1Breast 1

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 21Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Interventions

Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Glucose Intolerance × Other × Clear all
NCT07419074 2026-02-18

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

University of Lahore

Phase NA Completed
90 enrolled
Other

Obesity, Glucose Intolerance, Adenoma, Liver Cell

NCT03480022 2021-06-07

SAXAPCOS

Woman's

Phase 3 Completed
88 enrolled 35 charts
Other

Polycystic Ovary Syndrome, Prediabetic State, Weight Loss, Glucose Intolerance, Obesity, Abdominal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡